Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04K Buy
+16
New +$725 ﹤0.01% 3224
2025
Q4
– Sell
-22
Closed -$320 – 3390
2025
Q3
$320 Buy
+22
New +$314 ﹤0.01% 2992

Other funds holding CDNA

AssetMark's CDNA Position: Q3 2026 in Review

AssetMark opened a new position in CareDx (CDNA) in Q3 2026: 16 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #3224 among its holdings. This is a return to the name: AssetMark previously reported a position in CDNA as recently as Q3 2025.

AssetMark first reported a position in CDNA in Q3 2025 and has held it in 2 quarters since. 223 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • AssetMark held 16 shares of CareDx worth $1.04K as of Q3 2026.
  • CareDx was a new AssetMark position in Q3 2026.
  • CareDx made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3224 holding.
  • AssetMark first reported a position in CareDx in Q3 2025 and has held it in 2 quarters since.
  • 223 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.